Introduction
Trichilemmal carcinoma (TLC) is a rare adnexal tumor related to the external hair sheath. It was first described by Headington in 1976 as a histologically invasive, cytologically atypical clear cell neoplasm of adnexal keratinocytes which is in continuity with the epidermis or follicular epithelium (1) .
Clinically TLC is most often seen in older people and occurs with equal frequency in men and women. Average age of onset is 40 years. The pathogenesis remains unclear; however, factors like actinic damage, long-term low-dose irradiation and transformation from benign trichilemmoma have been postulated. TLC usually occurs on exposed areas of the skin, predominantly the face. It appears as a tan or flesh-colored spot -usually an isolated lesion -that can resemble a wart and sometimes contains hair. Correct diagnosis is very important because the tumor is so rare that the physician may not immediately recognize it. Generally, it is only on pathological examination that this tumor can be correctly classified (2) .
We report what is, to the best of our knowledge, the first case of TLC in a young patient with xeroderma pigmentosa (XP).
Case Report
A 25-year-old man presented with a 23 years history of photophobia, vertigo, and widespread brown pigmentation. He also had a 4-year history of ulcerations on the left vermilion border of the upper lip near the corner of the mouth and on the right upper eyelid and medial canthus of the right eye. The lip lesion measured about 4 × 2 cm and the eye lesion about 1 ×1 cm (Fig. 1) (Fig. 3) . Nuclear pleomorphism and mitotic activity was seen in both cell populations. There was no evidence of keratinization. These features satisfied Headington's criteria, leading to a diagnosis of TLC (1). The patient was lost to follow up before a definitive excision could be performed.
Discussion
Skin adnexal neoplasms comprise a wide spectrum of benign and malignant tumors. They exhibit morphological differentiation toward one or more types of adnexal structures found in normal skin (3) . XP is a rare inherited autosomal recessive disease in which the skin cannot repair DNA damage caused by ultraviolet light. Kaposis (1800) was the first to describe this disease; it has since been reported worldwide and in all races. Affected individuals have a 2,000-fold increased risk of developing skin cancers. Basal cell carcinoma (BCC) is the most commonly associated carcinoma followed by squamous cell carcinoma (SCC), melanoma, and fibrosarcoma. There can be multiple basaliomas and other skin malignancies at a young age. Recurrent facial cancers and repeated surgical treatment for these in XP have important social and psychological implications that are not encountered with other cancers. The two most common causes of death in XP patients are metastatic malignant melanoma and squamous cell carcinoma (4).
Here we report a case of XP which was diagnosed only on clinical grounds due to characteristic features and was associated with TLC. This case report appears to be the first of its kind after a thorough MEDLINE and Pubmed search.
Headington first used the term TLC and originally described this neoplasm as a tumor of clear cells in continuity with a coexisting trichilemmoma. The tumor is derived from the outer root sheath epithelium of a hair follicle (5) . TLC has a predictably benign course, and there are no reliable histologic criteria to predict tumor aggressiveness (6) . In the present case, the lip lesion fulfilled Headington's criteria in terms of lobular arrangement, peripherally arranged hyperchromatic cells, centrally located glycogen-rich PAS-positive clear cells, and thickened basement membrane (7) . Pleomorphism and mitotic activity of tumor cells was also observed.
However, TLC must be differentiated from other malignant clear cell adnexal tumors such as clear cell BCC, clear cell SCC, and sebaceous carcinoma. The areas of clear cell change in clear cell BCC often involve a minor portion of an otherwise conventional basal cell carcinoma, and some of these clear cells in this neoplasm are simply the result of degenerative changes (8, 9) . Clear cell SCC lacks trichilemmal keratinization, lobular growth or adnexal extension. Sebaceous carcinomas demonstrate tumor lobules composed of eosinophilic cells at the periphery and absence of PAS positivity (2) .
It is imperative that the correct diagnosis is made promptly as TLC has an indolent clinical course in which metastasis is rare despite the cytologically malignant appearance. Treatment includes complete surgical excision with histologically documented clear margins due to its potential for locally aggressive growth and recurrence. Since this neoplasm is easily treated with excision, there is no suggested alternative or adjunctive therapy (10) .
The diagnosis of TLC, in addition to the more common basal cell carcinoma and squamous cell carcinoma, should be considered in cases of XP. This is because the prognosis is better and biological behavior more indolent for TLC than for other epithelial malignancies, leading to differences in treatment planning.
